Brown Trout Management »

Amphastar Pharmaceuticals In shares owned by Brown Trout Management

Quarter-by-quarter ownership of Amphastar Pharmaceuticals In shares owned by Brown Trout Management from 13F filings

Historical chart of Brown Trout Management investment in Amphastar Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals In held by Brown Trout Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals In by Brown Trout Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.0M 5.4k 914.64

More positions owned by Brown Trout Management

Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Chart Industries (GTLS)
Bandwidth Note 0.500% 4/0 (Principal)
Taylor Morrison Hom (TMHC)
Sabre Glbl Note 7.320% 8/0 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Mgp Ingredients Note 1.875%11/1 (Principal)
Veritone Note 1.750%11/1 (Principal)
Amphastar Pharmaceuticals In Note 2.000% 3/1 (Principal)
The Realreal Note 1.000% 3/0 (Principal)
Five9 Note 1.000% 3/1 (Principal)
Shake Shack Note 3/0 (Principal)
Etsy Note 0.250% 6/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv (HPE.PC)

View all positions for Brown Trout Management

Top funds holding Amphastar Pharmaceuticals In

Context Capital Management
DeepCurrents Investment Group
Oaktree Capital Management
Millennium Management
Empyrean Capital Partners
Camden Asset Management
Fort Baker Capital Management
Capstone Investment Advisors
Wellesley Investment Advisors
Kim
Morgan Stanley
Russell Investments
BlackRock
Calamos Advisors
Advent Capital Management

View all funds holding Amphastar Pharmaceuticals In